Neonatal screening for congenital adrenal hyperplasia: Experience and results in Argentina

Journal of Pediatric Endocrinology and Metabolism

Volumn 21, Issue 1, 2008, Pages 73-78

  Gruñeiro Papendieck, Laura ^a   Chiesa, Ana ^a   Mendez, Virginia ^a   Prieto, Laura ^a  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

Argentina; Congenital adrenal hyperplasia; Neonatal screening; Salt wasting; Simple virilizing

Indexed keywords

HYDROXYPROGESTERONE;

ADRENAL INSUFFICIENCY; ARGENTINA; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; FEMALE; FLUOROMETRY; FOLLOW UP; GESTATIONAL AGE; HUMAN; INCIDENCE; MALE; NEWBORN; NEWBORN SCREENING; PREMATURITY; SALT LOSING NEPHRITIS; SEX RATIO;

17-ALPHA-HYDROXYPROGESTERONE; ADRENAL HYPERPLASIA, CONGENITAL; ARGENTINA; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; MALE; NEONATAL SCREENING; RETROSPECTIVE STUDIES;

EID: 40449106443     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Miller WL. Genetics, diagnosis, and management of 21-hydroxylase deficiency. J Clin Endocrinol Metab 1994; 78: 241-246.
2. Miller WL, Levine LS. Molecular and clinical advances in congenital adrenal hyperplasia. J Pediatr 1987; 111: 1-17.
3. Steigert M, Schoenle EJ, Biason-Lauber A, Torresani T. High reliability of neonatal screening for congenital adrenal hyperplasia in Switzerland. J Clin Endocrinol Metab 2002; 87: 4106-4110.
4. Allen DB, Hoffman GL, Fitzpatrick P, Laessig R, Maby S, Slyper A. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels. J Pediatr 1997; 130: 128-133.
5. Therrell BL Jr, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 1998; 101: 583-590.
6. Pang S, Clerk A. Congenital adrenal hyperplasia due to 21 hydroxylase deficiency; newborn screening and its relationship to the diagnosis and treatment of the disorder. Screening 1993; 2: 105-139.
7. Pang SY, Wallace MA, Hofman L, Thuline HC, Dorche C, Lyon IC, Dobbins RH, Kling S, Fujieda K, Suwa S. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988; 81: 866-874.
8. Lebovitz RM, Pauli RM, Laxova R. Delayed diagnosis in congenital adrenal hyperplasia. Need for newborn screening. Am J Dis Child 1984; 138: 571-573.
9. Working Group on Neonatal Screening of the European Society for Paediatric Endocrinology. Procedure for neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res 2001; 55: 201-205.
10. Honour JW, Torresani T. Evaluation of neonatal screening for congenital adrenal hyperplasia. Horm Res 2001; 55: 206-211.
11. ISNS Standing Committee on Quality Assurance. Lexicon of terms to be used in newborn screening. http://www.isns-neoscreening.org/pdf/ Lexicon8.pdf (visited 16/11/2006).
12. Gruneiro-Papendieck L, Prieto L, Chiesa A, Bengolea S, Bossi G, Bergada C. Neonatal screening program for congenital adrenal hyperplasia: adjustments to the recall protocol. Horm Res 2001; 55: 271-277.
13. Cardoso CB, Fonseca AA, Oliveira Mde F, Pereira BB. [Congenital adrenal hyperplasia newborn screening: Rio de Janeiro experience] [in Portuguese]. Arq Bras Endocrinol Metabol 2005; 49: 112-119.
14. Balbi V, Gonzalez V, Patin J, Tournier A, Borrajo G, Pistaccio L, Marino R, Belgorosky A, Rivarola MAQ, Santucci Z. Seven years of screening for congenital adrenal hyperplasia in Buenos Aires province. Genotyping benefits. J Pediatr Endocrinol Metab 2006; 19 (Suppl 3): 1087 (Abst).
15. American Academy of Pediatrics, Section on Endocrinology and Committee on Genetics Technical Report. Congenital adrenal hyperplasia. Pediatrics 2000; 106: 1511-1518.
16. Van der Kamp HJ, Wit JM. Neonatal screening for congenital adrenal hyperplasia. Eur J Endocrinol 2004; 151 (Suppl 3): U71-75.
17. Van der Kamp HJ, Noordam K, Elvers B, Van Baarle M, Otten BJ, Verkerk PH. Newborn screening for congenital adrenal hyperplasia in the Netherlands. Pediatrics 2001; 108: 1320-1324.
18. Cutfield WS, Webster D. Newborn screening for congenital adrenal hyperplasia in New Zealand. J Pediatr 1995; 126: 118-121.
19. Kovacs J, Votava F, Heinze G, Solyom J, Lebl J, Pribilincova Z, Frisch H, Battelino T, Waldhauser F; Middle European Workshop on Paediatric Endocrinology-Congenital Adrenal Hyperplasia Study Group. Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal hyperplasia in five middle European countries. J Clin Endocrinol Metab 2001; 86: 2958-2964.
20. Ordookhani A, Mirmiran P, Hajipour R, Hedayati M, Azizi F. Screening for congenital hypothyroidism in the Islamic Republic of Iran: strategies, obstacles and future perspectives. East Mediterr Health J 2002; 8: 480-489.